首页> 外文期刊>National Journal of Medical Research >INDICATIONS AND COMPLICATIONS OF CENTRAL VENOUS CATHETERIZATION IN CRITICALLY ILL CHILDREN IN INTENSIVE CARE UNIT
【24h】

INDICATIONS AND COMPLICATIONS OF CENTRAL VENOUS CATHETERIZATION IN CRITICALLY ILL CHILDREN IN INTENSIVE CARE UNIT

机译:重症监护病房危重儿童中心静脉导管的适应症和并发症

获取原文
       

摘要

Background: Nothing can be more difficult, time consuming and frustrating than obtaining vascular access in critically ill pediatric patient1 .Central venous catheters are widely used in the care of critically ill patients. Methodology: This paper reviews our experience with central lines in 28 critically ill patients including neonates and non-neonates, in a study period of October 2008 to October 2009. Of the total 28 patients, central venous catheterizations was more in those who were more than a month age and of female sex. Results: The route of insertion was femoral in approximately 89% of our patients and insertion was successful in 24 patients. The most common indication we observed for catheter use was, venous access in shock (37.1%) in neonates and for monitoring the central venous pressure (32%) in non neonate patients of ARDS with pulmonary edema and Shock. The central line was removed in majority of patients (60%) within 24-48hrs of insertion and was kept for maximum of six days in just one patient. Organism most frequently isolated was Acinetobacter. Recommendations made include, use strict aseptic measures by restricted number of skilled operators while inserting and during maintaining central line, routine confirmatory x-ray or fluoroscopy to check the position of central line before catheter use, if possible, use for central pressure monitoring recommended. Conclusion: We concluded that central venous catheterization is a safe and effective measure so we recommend timely and judicious use of percutaneous central venous catheter in paediatric critically ill patients of PICU and NICU.
机译:背景:重症儿科患者获得血管通路比这更困难,耗时和令人沮丧。中央静脉导管广泛用于重症患者的护理。方法:在2008年10月至2009年10月的研究期间,本文回顾了我们对28例危重患者(包括新生儿和非新生儿)的中心线治疗的经验。在全部28例患者中,中心静脉导管插入术的患者更多一个月大的女性。结果:大约89%的患者插入途径为股骨,24例患者成功插入。我们观察到的使用导管的最常见指征是新生儿休克时的静脉通路(37.1%),以及在非新生儿ARDS合并肺水肿和休克的患者中监测中心静脉压(32%)。在插入后的24至48小时内,大多数患者(60%)的中心线被拔出,仅一名患者最多保留了六天。最常分离的生物是不动杆菌。提出的建议包括:在插入中心线和维护中心线期间,使用有限数量的熟练操作人员采取严格的无菌措施,进行常规的X线检查或荧光透视检查,以确保在使用导管之前检查中心线的位置,如果可能,建议用于中心压力监测。结论:我们得出结论,中心静脉导管插入术是一种安全有效的措施,因此我们建议在PICU和NICU的小儿重症患者中及时,明智地使用经皮中心静脉导管。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号